Clinical Trials Logo

Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients clinical trials

View clinical trials related to Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients.

Filter by:
  • None
  • Page 1

NCT ID: NCT00363116 Completed - Clinical trials for Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

Start date: April 1999
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine the safety and efficacy of two dosing regimens of daclizumab in simultaneous kidney/pancreas transplant recipients.